Arrhythmic Mitral Valve Prolapse in the Young: A Rare but Concerning Entity

Arrhythmic mitral valve prolapse (MVP) is an increasingly recognized clinical entity, characterized by the association of myxomatous mitral valve, ventricular arrhythmias (VAs) and sudden cardiac death (SCD). Prevalence of MVP is reported ranging between 2% and 5% of the general population, and risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Nicolò, Cipriani, Alberto, Martini, Bortolo, Bauce, Barbara, Perazzolo Marra, Martina, Iliceto, Sabino, Corrado, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Interesting Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318567/
https://www.ncbi.nlm.nih.gov/pubmed/35885425
http://dx.doi.org/10.3390/diagnostics12071519
Descripción
Sumario:Arrhythmic mitral valve prolapse (MVP) is an increasingly recognized clinical entity, characterized by the association of myxomatous mitral valve, ventricular arrhythmias (VAs) and sudden cardiac death (SCD). Prevalence of MVP is reported ranging between 2% and 5% of the general population, and risk of SCD is estimated approximately 0.3% per year. Diagnosis of MVP and the occurrence of fatal events involve generally adults aged 30 to 50 years, whereas in younger and even pediatric individuals has rarely been described. Herein, we report two clinical cases of malignant MVP in young patients, with the aim to point out the clinical features and the challenge of clinical management and risk stratification.

Ejemplares similares